| Literature DB >> 25999596 |
Avijit Ray1, Luman Wang2, Bonnie N Dittel3.
Abstract
Although classically B cells are known to play important roles in immune protection via humoral immunity, recently their regulatory mechanisms have been best appreciated in the context of autoimmunity. Several studies have identified different subsets of regulatory B cells that vary not only in their phenotype but also in their mechanism of action. Although the best-studied mechanism of B-cell immune regulation is IL-10 production, other IL-10-independent mechanisms have been proposed. These include maintenance of CD4(+)Foxp3(+) regulatory T cells; production of transforming growth factor-β, IL-35, IgM or adenosine or expression of PD-L1 (programmed death 1 ligand 1) or FasL (Fas ligand). Given that B-cell-targeted therapy is being increasingly used in the clinic, a complete understanding of the mechanisms whereby B cells regulate inflammation associated with specific diseases is required for designing safe and effective immunotherapies targeting B cells. © The Japanese Society for Immunology. 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: CIA; EAE; GVHD; SLE; autoimmunity; colitis; diabetes; regulatory B cell
Mesh:
Substances:
Year: 2015 PMID: 25999596 DOI: 10.1093/intimm/dxv033
Source DB: PubMed Journal: Int Immunol ISSN: 0953-8178 Impact factor: 5.071